EAST BRUNSWICK, N.J./PRNewswire/ -- Grace Therapeutics, a clinical stage biopharmaceutical company focused on rare and orphan diseases, announced today that it is scheduled to speak at the J.P. Morgan Healthcare Conference in San Francisco.
Grace's presentation is scheduled for Thursday, January 10, 2019 at 9.00 a.m. Pacific Time. The management team invites you to attend the session and will also be available to meet during the week.
